AXON vs RTX: Which Is the Better Buy in 2026?
Last updated October 2026
Short answer
RTX is the larger of the two ($261.36B market cap): the incumbent the market prices for continued execution (24.64x forward earnings, beta 0.31). AXON is the smaller challenger ($31.71B), actually pricier on forward earnings (37.01x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
AXON vs RTX: the tie-breaker metrics
Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | AXON | RTX | What it tells you |
|---|---|---|---|
| Market cap | $31.71B | $261.36B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 37.01 | 24.64 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 161.95 | 34.14 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 1.44 | 0.31 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 12% of range | 53% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 8.63 | 3.94 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: RTX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how AXON and RTX affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AXON and RTX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AXON and RTX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Axon Enterprise (AXON) do?
Axon Enterprise (formerly TASER International) is the dominant supplier of body-worn cameras, in-car video, and conducted electrical weapons (TASERs) to law enforcement worldwide. The company also operates Axon Evidence (Evidence.com), the cloud-based digital evidence management platform that integrates video, audio, and case records, and Axon Records (records management system). Each Axon hardware device generates data that gets stored, processed, and analyzed in Axon's cloud platform, creating a recurring SaaS revenue stream.
What does RTX Corporation (RTX) do?
RTX Corporation (RTX), formerly Raytheon Technologies, is one of the world's largest aerospace and defense companies. It operates three businesses. Collins Aerospace supplies avionics, interiors, actuation, and other systems for commercial and military aircraft. Pratt & Whitney designs and manufactures jet engines for airliners (including the geared turbofan) and military aircraft, and earns substantial recurring revenue from servicing its large installed engine base. Raytheon, the defense segment, builds missiles, missile defense systems (including Patriot), radars, and other advanced defense electronics for the US military and allied governments.
AXON vs RTX: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- AXON drivers: AI-powered features; International expansion.
- RTX drivers: Commercial aftermarket; Defense backlog and missiles.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Public sector budget cycles affect short-term revenue, and Axon's year is weighted toward Q4, so a slip in year-end government orders can move results. For RTX, rTX faces program-execution risks, most visibly the Pratt & Whitney geared-turbofan powder-metal inspection issue that forced costly engine removals and weighed on cash.
AXON or RTX: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick AXON if you believe its drivers more; RTX if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AXON and RTX guides.
AXON vs RTX: the full fundamentals
AXON. Axon still trades at one of the highest valuations in public sector technology, a premium built on the dominant position in law enforcement video and TASERs, the high-margin SaaS conversion, and the AI feature roadmap. The premium has compressed hard in 2026, however: price to sales has roughly halved from about 25x to about 10x as the share price fell about 29% year to date while revenue grew more than 30%. Nineteen analysts carry an average target near $691 (a consensus Buy), far above the October 16, 2026 close of $400.90; consensus for Q3 2026, reported November 3, is about $939 million of revenue and $1.94 of EPS.
RTX. RTX trades as a large, dividend-paying aerospace and defense blue chip, now at about 34 times trailing and 24 times forward earnings after a 22% one-year gain. The premium rests on double-digit revenue growth, four straight quarterly EPS beats and about $9.9 billion of trailing free cash flow, weighed against program-execution risk like the geared-turbofan issue. Q3 2026 results on October 20 (consensus EPS about $1.78 on about $24.1 billion of revenue) are the next check.
Headline figures (approximate, October 2026): AXON shows revenue (ttm) ~$3.22 billion, revenue growth (q2 2026) ~35% YoY, 2026 revenue growth guidance ~32-34%, net income (ttm) ~$199 million (GAAP, ~6% margin); RTX shows revenue (ttm) ~$93.5 billion, revenue growth (q2 2026, yoy) ~14.5%, operating margin ~12.7%, net income (ttm) ~$7.7 billion.
The bottom line: AXON vs RTX
AXON and RTX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AXON and RTX exposure against your real portfolio. It is not an investment adviser.
Wondering how AXON or RTX fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Axon Enterprise with AI
Connect the broker you already use and ask Walnut's AI how AXON fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between AXON and RTX?
+
Axon Enterprise (formerly TASER International) is the dominant supplier of body-worn cameras, in-car video, and conducted electrical weapons (TASERs) to law enforcement worldwide. RTX Corporation (RTX), formerly Raytheon Technologies, is one of the world's largest aerospace and defense companies. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is AXON or RTX the better stock?
+
Neither is universally better. RTX is the larger incumbent; AXON is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, AXON or RTX?
+
On forward P/E (as of October 2026), AXON trades at 37.01x and RTX at 24.64x, so RTX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both AXON and RTX?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of AXON vs RTX?
+
AXON: Public sector budget cycles affect short-term revenue, and Axon's year is weighted toward Q4, so a slip in year-end government orders can move results. Regulatory debates around law enforcement technology (facial recognition, predictive policing) constrain some product features, and product liability and wrongful-death litigation tied to TASERs is an ongoing exposure. Competition from Motorola Solutions in body-worn cameras has intensified. Valuation is the risk the market has been pricing in 2026: even after the decline, AXON trades at about 166x trailing GAAP earnings, 38x forward earnings and 10x sales, and the stock fell about 14% in a day after a Q2 beat. GAAP margins are thin (operating margin near 5%) because of stock-based compensation and acquisition spending, and the September 2026 $1 billion convertible note offering lifts total debt to about $1.85 billion and raises potential dilution. RTX: RTX faces program-execution risks, most visibly the Pratt & Whitney geared-turbofan powder-metal inspection issue that forced costly engine removals and weighed on cash. Defense contracts can carry fixed-price exposure, supply-chain and labor pressures, and dependence on government budgets and procurement timing. Commercial aerospace is cyclical and sensitive to airline health, fuel prices, and travel demand. Large pension, warranty, and regulatory liabilities add complexity, and the stock can be hit by single-program problems given its size. Debt of about $38.9 billion against about $8.3 billion of cash limits flexibility. Valuation is another consideration: at about 34 times trailing and 24 times forward earnings, the shares price in continued growth, and some analysts trimmed targets in October 2026 (RBC cut its target to $235 from $250). Geopolitical shifts cut both ways: they support defense demand but introduce export-control and policy risk. Margins depend on disciplined execution across many long-cycle programs.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell AXON or RTX; figures are approximate and dated (as of October 2026). Verify current data before investing.